B2C Consumer App / Platform
Hims & Hers vs WHOOP
Structured technology and market comparison · 2026
Direct Feature Comparison
Hims & Hers · vs · WHOOPConsumer telehealth platform with subscription-based treatment and fulfilment.
Subscription wearable platform for continuous health, recovery and performance insights.
Analyze all overlapping signals and tech stacks for Hims & Hers and WHOOP
Compare mutual enterprise clients, monetization models, live market signals, and partner networks directly in the interactive Knowledge Graph.
Comparison Analysis
What is the main difference between Hims & Hers and WHOOP?
When comparing Hims & Hers and WHOOP, both platforms operate within the B2C Consumer App / Platform ecosystem. Hims & Hers is positioned as Consumer telehealth platform with subscription-based treatment and fulfilment, whereas WHOOP focuses on Subscription wearable platform for continuous health, recovery and performance insights. Decision-makers evaluate both solutions when orchestrating their commercial monetization and technology stack.
What are the top alternatives to Hims & Hers and WHOOP?
When evaluating Hims & Hers and WHOOP, enterprise buyers also consider other platforms in B2C Consumer App / Platform. You can discover the full competitive landscape and evaluate other alternatives by viewing their respective footprint profiles on Polaris7.
How do the corporate scale, structure, and headquarters of Hims & Hers and WHOOP compare?
Hims & Hers is headquartered in US (founded in 2017) with 1,001–5,000 employees. WHOOP is based in US (founded in 2012) with 501–1,000 employees. Complete ownership, subsidiary trees, and corporate affiliations are documented across Polaris7.
Market Signals
Recent Market Signals & Activity: Hims & Hers vs WHOOP
Documented market movements, strategic partnerships, product releases, and regulatory developments mapped across Polaris7.
Hims & Hers
Recent Signals
- ·PR Newswire: Advertising & MarketingPrivacy
Hims & Hers Securities Class Action Deadline Nov 2, 2026
Robbins Geller Rudman & Dowd LLP announces a securities class action lawsuit against Hims & Hers Health, Inc. (NYSE: HIMS) for alleged violations of the Securities Exchange Act. Investors who purchased securities between August 4, 2025 and July 29, 2026 have until November 2, 2026 to seek lead plaintiff appointment. The lawsuit follows an FTC complaint alleging Hims & Hers shared sensitive health information with third-party advertising platforms like Meta and Snap, and misled consumers about billing. The stock dropped nearly 15% upon the FTC news. Lead plaintiff process outlined under the Private Securities Litigation Reform Act.
- FTC filed a lawsuit against Hims & Hers on July 29, 2026, alleging sharing of sensitive health data with advertising platforms.
- Hims & Hers stock declined nearly 15% following the FTC announcement.
- Robbins Geller Rudman & Dowd LLP filed a class action lawsuit (Velanki v. Hims & Hers Health, Inc.) in the Northern District of California.
- ·SEC APIfinancials
10-Q Financial Filing Analysis for Hims & Hers (2026-08-10)
Hims & Hers reported Q2 2026 revenue of $753.2 million, up 38% year-over-year, and six-month revenue of $1.36 billion (+20% YoY), driven by strong expansion in the Hers brand and international growth from acquisitions including Eucalyptus. However, the company experienced a GAAP net loss of $86.3 million for Q2 2026 (compared to net income of $42.5 million in Q2 2025), primarily impacted by a strategic transition in its U.S. GLP-1 weight loss business, non-recurring restructuring charges, increased fulfillment costs from shorter shipping cadences, and a $60 million FTC legal contingency accrual.
- Q2 2026 total revenue reached $753.21 million (+38% YoY) with ending subscribers expanding 19% YoY to 2.89 million.
- GAAP net loss was $86.29 million for Q2 2026, down from net income of $42.51 million in Q2 2025, while Adjusted EBITDA stood at $60.32 million.
- Recorded a $60.0 million legal contingency accrual related to an FTC and multi-state consumer protection lawsuit regarding subscription and cancellation practices.
- ·PR Newswire: Technology NewsPrivacy
Hims & Hers Securities Fraud Class Action Filed
A securities fraud class action lawsuit has been filed against Hims & Hers Health, Inc. (NYSE: HIMS) in the U.S. District Court for the Northern District of California. The suit alleges the telehealth company disclosed sensitive health information to third-party advertising platforms, including Snap and Meta (Facebook), without proper consent, and misled consumers about billing practices. The FTC filed a related lawsuit on July 29, 2026, causing the stock to drop 14.73% to $25.00. Investors who purchased HIMS securities between August 4, 2025, and July 29, 2026, have until November 2, 2026, to apply as lead plaintiff. The case, Velanki v. Hims & Hers Health, Inc. et al., is being publicized by law firms including Kahn Swick & Foti, Kessler Topaz Meltzer & Check, and the Law Offices of Howard G. Smith.
- FTC sued Hims & Hers for sharing sensitive health data with advertising platforms (Snap, Meta) and deceptive billing practices.
- Hims & Hers stock dropped $4.32 (14.73%) to $25.00 on July 29, 2026.
- Class action lawsuit filed; lead plaintiff deadline is November 2, 2026.
WHOOP
Recent Signals
- ·t3nHardware & Gadgets
Apple Shelves AI Wearable Pin, Shifts Focus to Fitness Band
According to a Bloomberg report, Apple has halted development of its rumored AI-powered wearable pin, a device the size of an AirTag that could be pinned to clothing or worn as a pendant. The pin was intended to use cameras and microphones to feed information to Siri and Visual Intelligence for hands-free queries about the user's environment. Bloomberg suggests that upcoming AirPods with integrated cameras and smart glasses may render the pin redundant. Apple is now reportedly focusing on a display-less fitness band to compete with Whoop, which tracks fitness data via a smartphone app. The fitness band is described as a fabric band with sensors, similar to Whoop's design. This shift reflects Apple's realignment of its wearable strategy towards health and fitness rather than a separate AI accessory.
- Apple has paused development of an AI wearable pin according to a Bloomberg report.
- The pin was to be made of glass and aluminum, with a diameter similar to an AirTag but thicker.
- It was planned to include two cameras and three microphones to feed data to Siri and Visual Intelligence.
- ·t3nHealth & Fitness
Apple Revamps Health App with AI Insights and Readiness Score
Apple is overhauling its Health app, with the major update arriving in iOS 27.2. The new app will leverage Apple Intelligence to provide AI-powered insights, including a Readiness Score (0-10) for daily form, a 'Health Age' metric, and new vital signs such as heart rate variability. The update, initially available in English, introduces an 'Insights' tab, personal guidance, and enhanced longevity tracking. In the US, users will be able to order lab tests from Quest Diagnostics directly through the app, with results integrated into Health Age. The update is expected to launch in the fall, likely in November. The announcement follows Apple's recent keynote where the overhaul was teased. The revamped app aims to compete with wearables like Whoop by offering comprehensive health tracking and longevity features.
- Apple announced a major overhaul of its Health app, with the core features arriving in iOS 27.2.
- The new Health app includes AI-powered insights, a Readiness Score, and a 'Health Age' metric.
- iOS 27.2 will launch in Fall 2026, likely in November.
- ·Retail-NewsWearables
Apple Watch Ultra 4 focuses on health and on-device AI
Apple unveiled the Watch Ultra 4, positioning it as a health, fitness, and safety device. The new model features a redesigned health sensing system that measures heart rate every five seconds and more frequently tracks heart rate variability. A new 'Tagesform' (Daily Readiness) score combines activity, sleep, and vital data into a 0-10 score with actionable recommendations. The S11 chip enables more on-device AI processing for features like sound detection, supporting Apple's privacy-forward approach. Battery life reaches up to 50 hours normal, 84 hours low-power, and 45 hours continuous workout tracking, closing the gap with competitors like Garmin, Oura, and Huawei. Priced at €899 in Germany, the Ultra 4 underscores Apple's high-end wearable strategy amid a slowing smartwatch market, emphasizing data integration and ecosystem lock-in.
- Apple's Watch Ultra 4 is priced at €899 in Germany.
- It features a new health sensing system with heart rate measurement every five seconds and more frequent heart rate variability readings.
- A new 'Tagesform' readiness score integrates activity, sleep, and vitals into a 0-10 score.
Compare their exact ecosystem overlaps.
Explore all deep relationships in Polaris7. Discover exactly which mutual clients, integrated technologies, and overlapping partners Hims & Hers and WHOOP share across the market ecosystem.
Unlock full capability matrix, client overlaps & technology stacks